Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity - Wikidata - awgldk - TriplyDB

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

http://www.wikidata.org/entity/Q42409618

about

Non-alcoholic fatty liver disease: what the clinician needs to know.TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells Primary hepatocytes and their cultures in liver apoptosis research A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches Ameliorated ConA-induced hepatitis in the absence of PKC-theta Cellular inhibitor of apoptosis (cIAP)-mediated ubiquitination of phosphofurin acidic cluster sorting protein 2 (PACS-2) negatively regulates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity Genetic variation in APOJ, LPL, and TNFRSF10B affects plasma fatty acid distribution in Alaskan Eskimos.Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner.HIV induces TRAIL sensitivity in hepatocytes Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Maternal high fat diet is associated with decreased plasma n-3 fatty acids and fetal hepatic apoptosis in nonhuman primates.Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes.Toll-like receptors in the pathogenesis of alcoholic liver disease.Hepatocyte death: a clear and present danger.A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells Anti-lipoapoptotic effect of Artemisia capillaris extract on free fatty acids-induced HepG2 cells In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation Apoptosis as a mechanism for liver disease progression.Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis.The effect of miRNA-122 in regulating fat deposition in a cell line model.Foxp3 expression in liver correlates with the degree but not the cause of inflammation.A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis.Mechanisms of lipotoxicity in NAFLD and clinical implications Coinfection with HIV-1 and HCV--a one-two punch.Characterization of the role of tumor necrosis factor apoptosis inducing ligand (TRAIL) in spermatogenesis through the evaluation of trail gene-deficient mice.Mmu-miR-615-3p regulates lipoapoptosis by inhibiting C/EBP homologous protein Aryl hydrocarbon receptor-mediated induction of Stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.Death receptor 5 signaling promotes hepatocyte lipoapoptosis Lipids promote survival, proliferation, and maintenance of differentiation of rat liver sinusoidal endothelial cells in vitro.Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase.Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease research Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles.MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells Cellular and molecular mechanisms of liver injury.TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.

P2860

Q24563068-2E3F47C9-8BCC-4078-99D5-973D4B800DFC Q24605438-D402551B-8423-4FB6-891F-A28906850EA5 Q26828994-98EA4FF6-AE20-4C6D-BF5F-C131BEB59022 Q28392033-E1B5E495-C9C0-4736-94A4-DA454CAB8C7C Q28480548-BED1F88B-1DCF-4FF4-9258-030D4157D980 Q28540934-C0481A53-BC53-4245-BE34-AB72E1A166F8 Q30494507-CDEB0AF1-F9D3-4E4A-8A50-CEA666AC38C6 Q30701525-2B760709-4AE9-4657-97DE-ADC26AD68770 Q33413051-E41AF149-0676-442E-8AD0-F4DBCC8A7E6F Q33689591-8F7F0E48-0EAA-44B9-AF9A-6C83D50811FB Q33755829-7EF1B47F-C9AE-4F46-B822-4420FB2336AA Q33833752-60AF7C95-6BF3-46CE-95F9-C65479F4D2A2 Q33936548-1BEA88EF-2908-4E55-8A45-1B6E5A59D8EA Q34081462-8DF87689-30D3-486C-82FA-E01A63B0487A Q34106192-EE96663B-F7FD-4C96-B9A9-8028F0F75F16 Q34147508-62F8A63B-2924-4AEB-A35D-998818DF5D50 Q34212347-855568EB-21DD-4BF5-B779-27E8C3BF6CBB Q34468914-C99EA418-C51D-4EE0-AA8D-7949CC52C030 Q34708906-35B9F343-EE23-4366-923A-1CDD7764192A Q34764471-AD1A5DF1-9F24-43FD-8A13-53490F0424C0 Q34876724-4C82AE66-9195-411B-AC81-3483B93CBE78 Q35056293-9E269EE4-4E30-463B-BA06-FBD98A95BD1F Q35104601-320B0276-4E20-4B49-AEEF-B66FF7960517 Q35107291-17DEFE29-647A-4E00-9EA4-A325C91C20AE Q35122049-A03102B8-5496-4F96-BC41-CAD0209661EA Q35132916-38C5A05D-29D5-4E09-B8AC-B4081195EDB5 Q35137038-9F9364BA-AF2E-4B5D-BB61-60771B7EE8A8 Q35149525-3C6CD577-2276-4DC0-A246-E07F1ADC1CCC Q35330939-62C99FA6-0182-4F03-B7E8-D8158D18A698 Q35550990-EB209409-4BF4-4100-9A92-95DA18852840 Q35562084-A92C46A7-166E-4D93-AC3A-640B26CDAA99 Q35604362-F3A96D26-19B7-469E-ACB8-E0D8A93B3DEB Q35780887-A3D659AD-8983-4639-A019-C0C3294D9004 Q36044222-3FF2058C-D5E6-44DC-B746-1A136334EBE0 Q36129673-093F78A5-807B-4E57-8AC6-7D8EBC4BA89F Q36600231-DF5A8383-00B2-47D2-BA90-DF9908F3EE84 Q36759971-5A54BFAD-A0C0-419F-8014-CD04120A89D7 Q36908855-1134E2CD-EAC3-45D5-BE19-F3BA86C851DC Q36943407-35EB6394-3E70-491F-94D1-E101443940FF Q37029804-36BEF2D3-FFA9-4E2C-B691-4D0B1B6E6A37

P2860

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

http://www.wikidata.org/entity/Q42409618

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

@en

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

@nl

type

label

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

@en

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

@nl

prefLabel

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

@en

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

@nl

P1433

Q42409618-A098B241-F7C0-4AE3-83D0-CB8401BE888B

P1476

Q42409618-656EDAB2-78ED-4547-ACCE-56A82EC849FD

P2093

Q42409618-6DB295A0-3ABB-462E-B765-D25892700287

Q42409618-A7641E94-DA52-49B0-AE50-7426BF209F28

Q42409618-B1AE0CC9-1079-48D7-877D-CF29F194F81D

Q42409618-DB1FDB9E-E6DF-4FBD-B94B-231094223005

P2860

Q42409618-0FA8253C-15F9-4840-B665-3C2C8977F9B9

Q42409618-18651701-F20C-4F49-A85C-240BBF2B5029

Q42409618-308DC0BB-E50C-4548-B965-8D4AD7E7EA48

Q42409618-30D7D09B-3838-4883-A4B1-E2C14A87D30B

Q42409618-3B4E2970-2552-43C5-8F8C-FC5947DD2ADE

Q42409618-3D8F368E-5872-4CA9-AC77-A2DF2B0ABC50

Q42409618-3EC0C04C-81DE-4DFB-A9E0-BB4719E9E868

Q42409618-4E6FFBB8-427D-4119-950F-AE08265903FD

Q42409618-61A624B3-59EE-4640-A8AD-57B38B495316

Q42409618-64E4FFF9-AAC7-47F7-9A67-EB3FFFBF0E28

P304

Q42409618-9C97382B-5031-479B-B667-11E77BDDD70C

P31

Q42409618-75EF45F7-F3BA-4D4A-9188-3DC0165C574D

P356

Q42409618-72902228-E3F2-43D1-AC14-CE4DAD587FB9

P407

Q42409618-8DB61FBC-390C-4D5A-9492-9EAC27E098E9

P433

Q42409618-3EFB552A-5CB7-4794-B6DF-D9FDD41C1CD6

P478

Q42409618-9B910805-E8E0-472C-9F28-02EE92D405D7

P50

Q42409618-40481DFA-638B-4D50-A6C3-A28820C17018

P577

Q42409618-5AC15465-E992-4AB5-A18A-8C98CDA68386

P5875

Q42409618-4A9BE240-84A2-44D8-BA7D-CF7D546EB321

P698

Q42409618-9C4449F2-5C6C-4762-AC61-D536202CBC56

P921

Q42409618-7BCD34D0-882F-4C2D-ACAA-762255FD0819

Q42409618-7EE04875-D373-4626-9346-831E5466450F

P932

Q42409618-F3C647F1-603B-438A-BF99-5347622F0732

P356

GUT.2006.118059

P1433

P1476

Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity

@en

P2093

Fernando J Barreyro

http://www.w3.org/2001/XMLSchema#string

Hajime Isomoto

http://www.w3.org/2001/XMLSchema#string

Harmeet Malhi

http://www.w3.org/2001/XMLSchema#string

Steven F Bronk

http://www.w3.org/2001/XMLSchema#string

P2860

The receptor for the cytotoxic ligand TRAIL

Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene

Following a TRAIL: update on a ligand and its five receptors

The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover

A central role for JNK in obesity and insulin resistance

Bile acid regulation of C/EBPbeta, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes.

Differential regulation of the TRAIL death receptors DR4 and DR5 by the signal recognition particle

Regulation of p53 downstream genes.

P304

1124-1131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2006.118059

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Gregory J Gores

P577

2007-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6360517

http://www.w3.org/2001/XMLSchema#string

P698

17470478

http://www.w3.org/2001/XMLSchema#string

P921

P932

1955518

http://www.w3.org/2001/XMLSchema#string